Ovarian Cancer Treatment

Last Updated:

On This Page:

In 2011, 79.9% of stage III or IV ovarian cancer patients received chemotherapy.

Summary graph for Ovarian Cancer Treatment, Click to see detailed view of graph

See Graph Details

Introduction

Ovarian cancer forms in the tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed). Most ovarian cancers are either ovarian epithelial carcinomas (cancer that begins in the cells on the surface of the ovary) or malignant germ cell tumors (cancer that begins in egg cells). Cancerous ovarian tumors can also begin in stromal cells, which release hormones and connect the different structures of the ovaries, though this is less common.

The main treatments for ovarian cancer are surgery, chemotherapy, hormone therapy, targeted therapy, and radiation therapy. Often, two or more different treatments are used, though surgery is the main initial treatment for most ovarian cancers. Studies in early stage ovarian cancer have shown an increase in overall survival with the administration of chemotherapy, which is used in the majority of cases as a follow-up therapy to surgery.

Guidelines suggest intraperitoneal (IP) chemotherapy for later stage ovarian cancer. IP chemotherapy involves injecting a concentrated dose of drugs into the cancer cells in the abdominal cavity through a thin tube. In a study of women with advanced ovarian cancer, those receiving IP chemotherapy lived longer than those getting regular chemo, but the side effects were often more severe.

Measure

Percentage of individuals diagnosed with ovarian cancer who received chemotherapy by stage of diagnosis.

Healthy People 2020 Target

  • There are no Healthy People 2020 targets for cancer treatment, including ovarian cancer treatment.

Healthy People 2020 is a set of goals set forth by the Department of Health and Human Services.

Data Source

SEER Patterns of Care/Quality of Care Studies, National Cancer Institute,1991-2002.

Trends and Most Recent EstimatesHelp with navigating the graphs and data tables

Stage I and II Diagnoses

Percent of patients aged 20 years and older diagnosed with stage I or II ovarian cancer by type of treatment received, 1991-2011
Overview Graph Detailed Trend Graphs Most Recent Estimates (2011)
Percent of patients Confidence Interval
Thumbnail of graph for Percent of patients aged 20 years and older diagnosed with stage I or II ovarian cancer by type of treatment received, 1991-2011 ChemotherapyClick to see the detailed trend graph for Chemotherapy 63.5 (59.5 - 67.4)
Hormone therapyClick to see the detailed trend graph for Hormone therapy 0.7 (0.1 - 1.2)

Stage III and IV Diagnoses

Percent of patients aged 20 years and older diagnosed with stage III or IV ovarian cancer by type of treatment received, 1991-2011
Overview Graph Detailed Trend Graphs Most Recent Estimates (2011)
Percent of patients Confidence Interval
Thumbnail of graph for Percent of patients aged 20 years and older diagnosed with stage III or IV ovarian cancer  by type of treatment received, 1991-2011 ChemotherapyClick to see the detailed trend graph for Chemotherapy 79.9 (77.2 - 82.5)
Hormone therapyClick to see the detailed trend graph for Hormone therapy 0.6 (0.2 - 1.0)

Distribution of Chemotherapeutic Agents

Distribution of chemotherapeutic agents given to ovarian cancer patients aged 20 years and older by type of treatment received, 2011
Overview graph Chemotherapy agent received Stage I and II Stage III and IV
Percent of patients receiving agent Confidence Interval Percent of patients receiving agent Confidence Interval
Thumbnail of graph for Distribution of chemotherapeutic agents given to ovarian cancer patients aged 20 years and older by type of treatment received, 2011 Carboplatin/Cisplatin 61.1 (56.9 - 65.1) 77.5 (74.5 - 80.2)
Cyclophosphamide (Cytoxan) 0.1 (0.0 - 0.4) 0.6 (0.3 - 1.0)
Paclitaxol (Taxol) 53.3 (49.1 - 57.5) 72.6 (69.5 - 75.4)
Other Chemo Agents 15.7 (12.9 - 19.1) 30.7 (27.7 - 34.0)

Additional Information on Ovarian Cancer Treatment

For the public

For health professionals

Statistics

Year Range

1991-2011

Recent Summary Trend Year Range

2002-2011

Summary Tables

Kidney, Lung, Ovarian, Prostate

Recent Summary Trend

Rising

Desired Direction

Rising